RU2014134845A - Терапевтическое средство против диабета - Google Patents
Терапевтическое средство против диабета Download PDFInfo
- Publication number
- RU2014134845A RU2014134845A RU2014134845A RU2014134845A RU2014134845A RU 2014134845 A RU2014134845 A RU 2014134845A RU 2014134845 A RU2014134845 A RU 2014134845A RU 2014134845 A RU2014134845 A RU 2014134845A RU 2014134845 A RU2014134845 A RU 2014134845A
- Authority
- RU
- Russia
- Prior art keywords
- therapeutic
- group
- impaired glucose
- prophylactic agent
- glucose metabolism
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 17
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract 6
- 230000000069 prophylactic effect Effects 0.000 claims abstract 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract 13
- 201000010099 disease Diseases 0.000 claims abstract 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 10
- 230000004153 glucose metabolism Effects 0.000 claims abstract 10
- 230000001771 impaired effect Effects 0.000 claims abstract 10
- WYKHSBAVLOPISI-UHFFFAOYSA-N 2-phenyl-1,3-thiazole Chemical class C1=CSC(C=2C=CC=CC=2)=N1 WYKHSBAVLOPISI-UHFFFAOYSA-N 0.000 claims abstract 4
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims abstract 3
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims abstract 2
- 208000002705 Glucose Intolerance Diseases 0.000 claims abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 2
- 239000003472 antidiabetic agent Substances 0.000 claims abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 2
- 229940125904 compound 1 Drugs 0.000 claims abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 2
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 2
- 229940126904 hypoglycaemic agent Drugs 0.000 claims abstract 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims abstract 2
- 201000009104 prediabetes syndrome Diseases 0.000 claims abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000006828 (C2-C7) alkoxycarbonyl group Chemical group 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012-015351 | 2012-01-27 | ||
| JP2012015351 | 2012-01-27 | ||
| PCT/JP2013/051627 WO2013111870A1 (ja) | 2012-01-27 | 2013-01-25 | 糖尿病の治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014134845A true RU2014134845A (ru) | 2016-03-20 |
Family
ID=48873581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014134845A RU2014134845A (ru) | 2012-01-27 | 2013-01-25 | Терапевтическое средство против диабета |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150005506A1 (enExample) |
| EP (1) | EP2808018B1 (enExample) |
| JP (1) | JP5924699B2 (enExample) |
| KR (1) | KR20140134266A (enExample) |
| CN (1) | CN104066430A (enExample) |
| AR (1) | AR089812A1 (enExample) |
| AU (1) | AU2013212865A1 (enExample) |
| BR (1) | BR112014017902A2 (enExample) |
| CA (1) | CA2862602A1 (enExample) |
| HK (1) | HK1201209A1 (enExample) |
| IN (1) | IN2014DN05972A (enExample) |
| MX (1) | MX2014008484A (enExample) |
| RU (1) | RU2014134845A (enExample) |
| TW (1) | TW201334779A (enExample) |
| WO (1) | WO2013111870A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104628671B (zh) * | 2015-02-10 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途 |
| CN104610188B (zh) * | 2015-02-10 | 2016-07-27 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的腈基苯噻唑羧酸酰胺类化合物、其制备及用途 |
| CN104628673A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的腈基苯噻唑羧酸酰胺类化合物及用途 |
| CN104628672A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含苯基脒结构的烷氧苯基噻唑羧酸酰胺类化合物及用途 |
| CN104610190B (zh) * | 2015-02-10 | 2016-08-17 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途 |
| KR102473677B1 (ko) * | 2015-08-17 | 2022-12-02 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| US11344539B2 (en) | 2016-02-19 | 2022-05-31 | National University Corporation Tottori University | Therapeutic or prophylactic drug for dementia |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122008000051I1 (de) | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
| HUP9902721A2 (hu) * | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
| US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
| WO2006012438A2 (en) * | 2004-07-21 | 2006-02-02 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of insulin resistance |
| CA2617161A1 (en) * | 2005-07-21 | 2007-02-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| JP5242393B2 (ja) | 2005-08-03 | 2013-07-24 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | 高血圧症の治療方法 |
| EP1957064A4 (en) * | 2005-11-21 | 2010-01-06 | Tap Pharmaceutical Prod Inc | TREATMENT OF QT INTERVAL EXTENSION AND RELEVANT DISEASES |
| JP2007210978A (ja) * | 2006-02-13 | 2007-08-23 | Hiroshima Univ | 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤 |
| EP2101761A4 (en) | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
| BRPI0819847B1 (pt) * | 2007-11-27 | 2022-01-11 | Ardea Biosciences, Inc | Compostos e composições |
| US8394792B2 (en) * | 2008-03-31 | 2013-03-12 | C&C Research Laboratories | Heterocyclic derivatives |
| MX2010011603A (es) * | 2008-04-30 | 2011-01-25 | Wellstat Therapeutics Corp | Compuestos de tetrazol para reducir el acido urico. |
| BRPI0913129A2 (pt) * | 2008-05-22 | 2016-01-05 | Bristol Myers Squibb Co | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo |
| JP2012505925A (ja) * | 2008-10-19 | 2012-03-08 | リチャード ジェイ ジョンソン | 代謝不均衡に関連付けられる慢性腎疾患を治療するための治療組成物及び方法 |
| EP2470268A4 (en) * | 2009-08-24 | 2012-12-26 | Wound Man Pty Ltd | PURING-ORIENTED DIAGNOSIS AND THERAPY OF WOUNDS |
| US9248119B2 (en) * | 2010-06-16 | 2016-02-02 | Takeda Pharmaceuticals U.S.A., Inc. | Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors |
| PH12012502487A1 (en) * | 2010-06-25 | 2017-08-09 | Teijin Pharma Ltd | Sustained-release therapeutic agent for hypertension and renal dysfunction |
-
2013
- 2013-01-25 CA CA2862602A patent/CA2862602A1/en not_active Abandoned
- 2013-01-25 EP EP13740913.2A patent/EP2808018B1/en not_active Not-in-force
- 2013-01-25 JP JP2013555326A patent/JP5924699B2/ja not_active Expired - Fee Related
- 2013-01-25 AU AU2013212865A patent/AU2013212865A1/en not_active Abandoned
- 2013-01-25 WO PCT/JP2013/051627 patent/WO2013111870A1/ja not_active Ceased
- 2013-01-25 RU RU2014134845A patent/RU2014134845A/ru not_active Application Discontinuation
- 2013-01-25 BR BR112014017902A patent/BR112014017902A2/pt not_active IP Right Cessation
- 2013-01-25 KR KR1020147020342A patent/KR20140134266A/ko not_active Withdrawn
- 2013-01-25 TW TW102102886A patent/TW201334779A/zh unknown
- 2013-01-25 US US14/372,961 patent/US20150005506A1/en not_active Abandoned
- 2013-01-25 HK HK15101890.2A patent/HK1201209A1/xx unknown
- 2013-01-25 MX MX2014008484A patent/MX2014008484A/es unknown
- 2013-01-25 AR ARP130100233A patent/AR089812A1/es unknown
- 2013-01-25 IN IN5972DEN2014 patent/IN2014DN05972A/en unknown
- 2013-01-25 CN CN201380006730.6A patent/CN104066430A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2013111870A1 (ja) | 2015-05-11 |
| TW201334779A (zh) | 2013-09-01 |
| US20150005506A1 (en) | 2015-01-01 |
| AU2013212865A1 (en) | 2014-08-14 |
| HK1201209A1 (en) | 2015-08-28 |
| CN104066430A (zh) | 2014-09-24 |
| WO2013111870A1 (ja) | 2013-08-01 |
| BR112014017902A2 (pt) | 2017-08-22 |
| EP2808018A4 (en) | 2015-07-15 |
| IN2014DN05972A (enExample) | 2015-06-26 |
| KR20140134266A (ko) | 2014-11-21 |
| EP2808018B1 (en) | 2018-03-14 |
| EP2808018A1 (en) | 2014-12-03 |
| MX2014008484A (es) | 2014-10-14 |
| AR089812A1 (es) | 2014-09-17 |
| CA2862602A1 (en) | 2013-08-01 |
| JP5924699B2 (ja) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2015518491A5 (enExample) | ||
| RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
| MX358679B (es) | Derivado de anillo de heteroarilo de seis miembros de pirrol, método de preparación del mismo y usos médicos del mismo. | |
| ME02312B (me) | DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE | |
| EA201491671A1 (ru) | Гетероциклильные соединения | |
| RU2015100901A (ru) | Производные эфира гетероарилкарбоновой кислоты | |
| JP2018502101A5 (enExample) | ||
| AR055060A1 (es) | Derivados de n-(piridin-2-il)-sulfonamida | |
| NZ607580A (en) | N-heteroaryl compounds | |
| RU2015117251A (ru) | Новые соединения | |
| JP2012520342A5 (enExample) | ||
| NZ603465A (en) | Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient | |
| EA201400067A1 (ru) | Новая терапевтическая композиция, содержащая апоморфин в качестве активного ингредиента | |
| WO2013028818A8 (en) | Pyrimido- pyridazinone compounds and use thereof | |
| WO2010010288A3 (fr) | Derives de carbamates d' alkylthiazoles, leur preparation et leur utilisation comme inhbiteurs de l'enzyme faah | |
| RU2011121809A (ru) | Производное циклогексана и его фармацевтическое применение | |
| NZ602450A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| AR092960A1 (es) | Procedimiento para preparar compuestos tienopirimidina | |
| WO2014151871A3 (en) | Jak2 and alk2 inhibitors and methods for their use | |
| RU2015117647A (ru) | Новые производные пиразола | |
| AR089812A1 (es) | Agente terapeutico para la diabetes mellitus | |
| RU2016104844A (ru) | Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора | |
| EA201490630A1 (ru) | 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы | |
| MX2011012057A (es) | Derivados de ciclopenta [c] pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su uso en terapéutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20160830 |